Abstract Guideline

Abstract deadline submission extended: September 15th to October 17th, 2023

 Abstract Submission Here

Guideline for preparation and submission of abstracts

1. Abstracts may be submitted via the submission website only. Abstracts submitted via fax or e-mail will not be accepted.
2. All abstracts must be submitted and presented in English.
3. Please structure your abstract using the following headings:
   1. Objectives
   2. Methods
   3. Results
   4. Conclusions
      
      You can upload your abstract as a Word document.
      
      
4. The abstract text may not be longer than 500 words, excluding the title, authors, and author’s affiliation. Please use one affiliation per author/co-author
   1. The maximum number of 10 author and co-authors is allowed per submitted abstract.
      
   2. Tables, charts, and other graphics are permitted and must be in JPG or GIF format and of high resolution (max. 2 graphics per abstract).
5. Words of non-English origin, like, in vitro, in situ, should be placed in italic, together with scientific names of any rank (e.g., Aspergillus fumigatus, A. flavus, Candida albicans, Candida tropicalis).
6. After having submitted your abstract, you will immediately receive a confirmation by e-mail. If you wish to submit other abstracts later, you may use your personal access codes. Should you wish to make corrections to an abstract already submitted, please send an e-mail to: ekipe@ekipedeeventos.com.br. Corrections to abstracts can only be made up to the deadline of October 17th. If you do not receive a confirmation by e-mail, please contact the congress secretariat a ekipe@ekipedeeventos.com.br
7. Abstracts will be reviewed by at least 2 members of the Scientific Committee.
8. 25th October 2023 evolution will be announced and abstract letters of acceptance will be mailed.
9. Abstract authors must register for the congress by 17th - October 2023 or advise us of withdrawal by this date. Registration ensures publication and presentation.
10. If an abstract is accepted, the presenting author must attend the congress and present it in person.

Categories:

• Antifungal susceptibility
• Clinical management – Antifungal therapy
• Endemic Mycosis
• Eco-Epidemiology
• Fungal infections in the ICU
• Fungal infections in the immunocompromised host
• Fungal infections in the pediatric and neonatal population
• Laboratorial diagnosis, molecular biology, and proteomics
• One Health & Public Health
• Pharmacology. Pharmacokinetics and pharmacodynamics
• Superficial fungal infections

The Scientific Committee will make the selection of abstracts for oral and poster presentations.

Abstracts can only be submitted online.